Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

96
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
96
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

175
Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
175
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

143
Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
143
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

147
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
147
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

110
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
110
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

3.4K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Anaemia and iron deficiency in chronic heart failure patients].

Kardiologiia·2019
Same author

[The case of repeated syncopes in recurrent pulmonary embolism].

Kardiologiia·2018
Same author

RELATIONSHIP BETWEEN BLOOD ALDOSTERONE AND SOMATOMETRIC PARAMETERS IN PATIENTS WITH CHRONIC HEART FAILURE AND PRESERVED EJECTION FRACTION OF LEFT VENTRICLE.

Klinicheskaia meditsina·2017
Same author

[Infective endocarditis in the elderly: The current view of the problem].

Terapevticheskii arkhiv·2017
Same author

[Sudden Cardiac Death in Patients With Hypertrophic Cardiomyopathy].

Kardiologiia·2017
Same author

[The Development of Pulmonary Damage When Receiving Amiodarone].

Kardiologiia·2017

Related Experiment Video

Updated: Nov 19, 2025

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues
07:50

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues

Published on: January 7, 2019

7.1K

[Antibiotic prophylaxis for infective endocarditis: current approaches].

G G Taradin1, N T Vatutin1, G A Ignatenko1

  • 1State Educational Organization of Higher Professional Education "M. Gorky Donetsk National Medical University", Donetsk, Ukraine.

Kardiologiia
|February 1, 2021
PubMed
Summary
This summary is machine-generated.

This review examines infectious endocarditis (IE) prevention, focusing on antibacterial prophylaxis (ABP) guidelines. It evaluates changes in ABP recommendations and their impact on IE incidence and complications.

More Related Videos

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials
06:18

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials

Published on: March 3, 2023

1.7K
In Vivo Mouse Model of Spinal Implant Infection
08:03

In Vivo Mouse Model of Spinal Implant Infection

Published on: June 23, 2020

2.6K

Related Experiment Videos

Last Updated: Nov 19, 2025

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues
07:50

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues

Published on: January 7, 2019

7.1K
A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials
06:18

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials

Published on: March 3, 2023

1.7K
In Vivo Mouse Model of Spinal Implant Infection
08:03

In Vivo Mouse Model of Spinal Implant Infection

Published on: June 23, 2020

2.6K

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Public Health

Background:

  • Infectious endocarditis (IE) remains a significant clinical challenge.
  • Antibacterial prophylaxis (ABP) is a cornerstone of IE prevention strategies.
  • Evolving guidelines necessitate a review of current practices.

Purpose of the Study:

  • To provide a comprehensive overview of current infectious endocarditis prevention strategies.
  • To critically evaluate recent changes and international guidelines for antibacterial prophylaxis.
  • To assess the impact of guideline modifications on IE morbidity and clinical outcomes.

Main Methods:

  • Systematic review of international and national guidelines (ESC, AHA/ACC, JCS).
  • Critical analysis of historical development and recent shifts in antibacterial prophylaxis recommendations.
  • Evaluation of IE morbidity and complication incidence related to ABP restrictions.
  • Assessment of preventive strategies for cardiac electronic devices and transcatheter aortic valve implantation.

Main Results:

  • Recent guidelines show shifts in antibacterial prophylaxis recommendations for IE prevention.
  • Analysis indicates potential impact of ABP restrictions on IE incidence and complications.
  • Dentists' awareness of ABP guidelines requires attention.
  • Specific considerations for IE prevention in device implantation and TAVI procedures are highlighted.

Conclusions:

  • Current views on IE prevention, particularly antibacterial prophylaxis, are evolving.
  • Adherence to and understanding of updated guidelines are crucial for effective IE prevention.
  • Further research may be needed to fully elucidate the long-term effects of guideline changes.